Investigation of human papillomavirus and Epstein-Barr virus DNAs in pterygium tissue

European Journal of Ophthalmology

Volumn 19, Issue 2, 2009, Pages 175-179

  Otlu, Baris ^a   Emre, Sinan ^b   Turkcuoglu, Peykan ^a   Doganay, Selim ^a   Durmaz, Riza ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

EBV; HPV; Pterygium; Real time PCR

Indexed keywords

VIRUS DNA;

ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTERYGIUM; REAL TIME POLYMERASE CHAIN REACTION; VIRUS IDENTIFICATION; WART VIRUS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PAPILLOMA VIRUS; RECURRENT DISEASE; VIRAL EYE INFECTION; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EYE INFECTIONS, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PTERYGIUM; RECURRENCE;

EID: 65249143448     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900201     Document Type: Article

References (26)

1. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004; 23: 195-228.
2. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999; 10: 282-8.
3. McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000; 84: 289-92.
4. Vojnikovi B, Njiri S, Coklo M, Toth I, Spanjol J, Marinovi M.Sunlight and incidence of pterygium on Croatian Island Rab - epidemiological study. Coll Antropol 2007; 31: 61-2.
5. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, Coroneo MT, Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol 2003; 162: 567-74.
6. Spandidos DA, Sourvinos G, Kiaris H, Tsamparlakis J. Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol 1997; 81: 493-6.
7. Tsai YY, Chang KC, Lin CL, et al. p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea 2005; 24: 583-6.
8. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 2001; 20: 164-7.
9. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998; 236: 702-8.
10. Lee DH, Cho HJ, Kim JT, Choi JS, Joo CK. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001; 20: 738-42.
11. Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003; 87: 864-6.
12. Gallagher MJ, Giannoudis A, Herrington CS, Hiscott P. Human papillomavirus in pterygium. Br J Ophthalmol 2001; 85: 782-4.
13. Schellini SA, Hoyama E, Shiratori CA, Sakamoto RH, Candeias JM.Lack of papillomavirus (HPV) in pterygia of a Brazilian sample. Arq Bras Oftalmol 2006; 69: 519-21.
14. Chen KH, Hsu WM, Cheng CC, Li YS. Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol 2003; 87: 1046-8.
15. Takács T, Jeney C, Kovács L, Mózes J, Benczik M, Sebe A. Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types. J Virol Methods 2008; 149: 153-62.
16. McDonnell JM, McDonnell PJ, Stout WC, et al. Human papillomavirus DNA in a recurrent squamous carcinoma of the eyelid. Arch Ophthalmol 1989; 107: 1631-4.
17. Lauer SA, Malter JS, Meier JR. Human papillomavirus type 18 in conjunctival intraepithelial neoplasia. Am J Ophthalmol 1990; 110: 23-7.
18. Karcioglu ZA, Issa TM. Human papilloma virus in neoplasia and non-neoplastic conditions of the external eye. Br J Ophthalmol 1997; 81: 595-8.
19. Antonishyn NA, Horsman GB, Kelln RA, Saggar J, Severini A. Arch Pathol Lab Med 2008; 132: 54-60.
20. Sjö NC, von Buchwald C, Prause JU, Norrild B, Vinding T, Heegaard S. Human papillomavirus and pterygium. Is the virus a risk factor? Br J Ophthalmol 2007; 91: 1016-8.
21. Varinli S, Varinli I, Köksal Erkisi M, Doran F. Human papillomavirus in pterygium. Cent Afr J Med 1994; 40: 24-6.
22. Ritterband DC, Friedberg DN. Virus infections of the eye. Rev Med Virol 1998; 8: 187-201.
23. Restelli M, Grinstein S, Gattuso P, et al. Immunolocalization of the Epstein-Barr nuclear antigen-1 in conjunctival squamous carcinomas and dysplasias. Hum Pathol 2005; 36: 325-9.
24. Walton RC, Onciu MM, Irshad FA, Wilson TD. Conjunctival posttransplantation lymphoproliferative disorder. Am J Ophthalmol 2007; 143: 1050-1.
25. Feinberg AS, Spraul CW, Holden JT, Grossniklaus HE. Conjunctival lymphocytic infiltrates associated with Epstein-Barr virus. Ophthalmology 2000; 107: 159-63.
26. Gilbert MT, Haselkorn T, Bunce M, et al. The isolation of nucleic acids from fixed, paraffin-embedded tissues: which methods are useful when? PLoS One 2007; 2: e537.